Virtual Group Resilient Living Program For Patients Living With Advanced Cancer
3 other identifiers
interventional
42
1 country
1
Brief Summary
This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Living Program (RLP) on anxiety, stress, quality of life (QOL), coping, and fatigue among patients with advanced cancer. The group RLP is a psychosocial intervention that consists of a total of 7 weekly sessions in which the interventionalist teaches the patients techniques on stress management and building resilience (mindfulness, uplifting emotions, reframe experiences through principles of gratitude, compassion, acceptance, meaning, and forgiveness). The group setting allows for support and connection amongst the patients, providing further support and motivation to practice the principles of the program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 15, 2026
CompletedStudy Start
First participant enrolled
June 19, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2027
July 2, 2026
June 1, 2026
1 year
June 15, 2026
June 30, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Enrollment Feasibility
Enrollment feasibility will be met if 42 patients are enrolled within a year.
Up to 1 year
Completion Feasibility
Completion feasibility will be met if at least 32 of 42 patients (≥75%) enrolled in the intervention arm attend at least 4 of the 7 program sessions.
Up to 1 year
Acceptability - Was it Worth it (WIWI)
measured by the three item responses from the Was It Worth It (WIWI) questionnaire. Acceptability will be met if at least 75% of respondents answer "Yes" to at least two out of the three items
After week 7 session
Secondary Outcomes (5)
Change in Anxiety - GAD-7
Baseline, after week 7 session, 30 days after week 7 session
Change in Stress - PSS
Baseline, after week 7 session, 30 days after week 7 session
Change in Quality of Life (QoL) - FACT-G
Baseline, after week 7 session, 30 days after week 7 session
Change in Coping - Brief COPE
Baseline, after week 7 session, 30 days after week 7 session
Change in Fatigue - PROMIS-Fatigue
Baseline, after week 7 session, 30 days after week 7 session
Study Arms (1)
Virtual Group Resilient Living Program
EXPERIMENTALParticipants will receive an invitation to 7 weekly 90-minute group RLP sessions. Study participation involves attending RLP sessions, and completing brief surveys related to health, well-being, and quality of life. There will also be online modules to watch and an accompanying journal (with prompts) to keep.
Interventions
The Resilient Living Program (RLP) is a virtual program consisting of online modules and virtual training sessions focused on techniques for managing stress and building resilience (mindful presence, uplifting emotions, and reframing experiences through principles of gratitude, compassion, acceptance, meaning, and forgiveness).
Participants will complete study-related surveys.
Eligibility Criteria
You may qualify if:
- English fluency
- Diagnosis of advanced (stage III/IV) malignancy
- Baseline distress score ≥ 4/10. Patients can answer questions orally rather than complete worksheet, if applicable
- Life expectancy of ≥ 6 months
- Provide informed consent
- Ability to complete questionnaire(s) by themselves or with assistance
- Has a reliable internet connection
- Has the ability to utilize technology to watch online modules, \& participate in virtual sessions
You may not qualify if:
- As determined through self-report, those diagnosed with a history of a psychotic episode ≤ 5 years
- All psychological co-morbidities such as a history of untreated schizophrenia, \& bipolar disease
- A diagnosis of severe cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Deirdre R. Pachman, MD
Mayo Clinic
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 15, 2026
First Posted
June 22, 2026
Study Start
June 19, 2026
Primary Completion (Estimated)
June 30, 2027
Study Completion (Estimated)
June 30, 2027
Last Updated
July 2, 2026
Record last verified: 2026-06